Fulminant hepatic failure in murine hepatitis virus strain 3 infection: Tissue-specific expression of a novel fgl2 prothrombinase

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9223-9230

  Ding, J W ^a   Ning, Q ^a   Liu, M F ^a   Lai, A ^a   Leibowitz, J ^b   Peltekian, K M ^c   Cole, E H ^a   Fung, L S ^a   Holloway, C ^d   Marsden, P A ^a,e   Yeger, H ^f   Phillips, M James ^a,f   Levy, Gary A ^a,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b TEXAS A AND M UNIVERSITY   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; FIBRIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRIN DEPOSITION; GENETIC TRANSCRIPTION; LIVER; LIVER FAILURE; LIVER NECROSIS; LIVER SINUSOID; LIVER VEIN; LUNG; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; RNA TRANSLATION; SPLEEN; TISSUE SPECIFICITY;

EID: 0030807894     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9223-9230.1997     Document Type: Article

References (33)

1. 2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J. Clin. Invest. 80:881-889.
2. Alexander, J. R., B. C. Sheppard, J. C. Jensen, H. Langstein, C. M. Buresh, D. Venzon, E. C. Walker, D. L. Fraker, M. C. Stovorff, and J. A. Norton. 1991.Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension and hypothermia of gram-negative sepsis. J. Clin. Invest. 88:34-39.
3. Buchmeier, M. J., H. A. Lewicki, P. J. Talbot, and R. L. Knobler. 1984. Murine hepatitis virus 4 (MHV-JHM) induced neurological disease is modulated in vivo by monoclonal antibody. Virology 132:261-270.
4. DeSouza, M. S., A. L. Smith, and K. Bottomly. 1991. Infection of Balb/cByJ mice with the JAM strain of mouse hepatitis virus alters in-vitro splenic T cell proliferation and cytokine production. Lab. Anim. Sci. 41:99-105.
5. Evans, R., and S. J. Kamdar. 1990. Stability of RNA isolated from macrophages depends on the removal of an RNA-degrading activity early in the extraction procedure. Biotechniques 8:357-360.
6. Fleming, J. O., R. A. Shubin, M. A. Sussman, N. Casteel, and S. A. Stohlman. 1989. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168:162-167.
7. Fung, L. S., G. Neil, J. Leibowitz, E. H. Cole, S. Chung, A. Crow, and G. A. Levy. 1991. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. J. Biol. Chem. 266:1789-1795.
8. Houtman, J. J., and J. O. Fleming. 1996. Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol. 2:361-270.
9. Janousek, J., E. Strmen, and F. Gervais. 1993. Purification of murine Kupffer cells by centrifugal elutriation. J. Immunol. Methods 164:109-117.
10. Koyama, S., L. R. Hall, H. G. Haser, S. Tonegawa, and H. Saito. 1987. Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen β and γ chains. Proc. Natl. Acad. Sci. USA 84:1609-1613.
11. Lamontagne, L., and P. Jolicoeur. 1991. Mouse hepatitis virus 3-thymic cell interactions correlating with viral pathogenecity. J. Immunol. 146:3152-3159.
12. Laskin, D. L. 1990. Nonparenchymal cells and hepatotoxicity. Semin. Liver Dis. 10:293-304.
13. Levy, G. A., J. L. Leibowitz, and T. S. Edgington. 1981. The induction of monocyte procoagulant activity by murine hepatitis virus MHV-3 parallels disease susceptibility in mice. J. Exp. Med. 154:1150-1163.
14. Levy, G. A., H. Helin, and T. S. Edgington. 1984. The pathobiology of viral hepatitis and immunologic activation of the coagulation protease network. Semin. Liver Dis. 4:59-68.
15. Li, C., L. S. Fung, A. Crow, N. Myers-Mason, M. J. Phillips, J. L. Leibowitz, E. Cole, C. A. Ottaway, and G. A. Levy. 1992. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J. Exp. Med. 176:689-697.
16. MacPhee, P. J., V. J. Dindans, L. S. Fung, J. L. Leibowitz, and G. A. Levy. 1985. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3. Hepatology 5:649-660.
17. Mori, W., and A. Naoto. 1981. Acute hepatic cell necrosis experimentally produced by viral agents in rabbits. Am. J. Pathol. 103:31-35.
18. Mori, W., J. Shiga, and H. Irie. 1986. Schwartzman reaction as a pathogenetic mechanism in fulminant hepatitis. Semin. Liver Dis. 6:267-269.
19. Ohlsson, K., P. Bjork, M. Bergenfeldt, R. Hageman, and R. C. Thompson. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (London) 348:550-552.
20. Parr, R. L., L. Fung, J. Reneker, N. Myers-Mason, J. L. Leibowitz, and G. A. Levy. 1995. Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity. J. Virol. 69:5033-5038.
21. Patton, J. S., P. M. Peters, J. McCable, D. Crase, S. Hansen, A. B. Chen, and D. Liggitt 1987. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents. J. Clin. Invest. 80:1587-1596.
22. Piazza, M. 1969. Experimental viral hepatitis. p. 1-274. Charles C. Thomas, Springfield, Ill.
23. Pope, M., O. Rotstein, E. Cole, S. Sinclair, R. Parr, B. Cruz, R. Fingerote, S. Chung, R. Gorczynski, L. Fung, J. Leibowitz, U. S. Rao, and G. A. Levy. 1995. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J. Virol. 69:5252-5260.
24. Portmann, B., I. C. Talbot, D. W. Day, A. R. Davidson, I. M. Murray-Lyon, and R. Williams. 1975. Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters. J. Pathol. 117:169-181.
25. Qureshi, S. T., S. Clermont, J. L. Leibowitz, G. A. Levy, and D. Malo. 1995. Mouse hepatitis virus-3 induced prothrombinase (Fg12) maps to proximal chromosome 5. Genomics 29:307-309.
26. Ribaudo, R., M. Gilman, R. E. Kingston, P. Chomczynski, and N. Sacchi. 1991. Single-step RNA isolation from cultured cells or tissues, p. 10.11.7-10.11.14. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology, supplement 3. John Wiley & Sons, Inc., New York, N.Y.
27. Seglen, P. O. 1973. Preparation of rat liver cells. Exp. Cell Res. 82:391-398.
28. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey, A. Zentalla, J. D. Albert, et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
29. Tracey, K. J., S. F. Lowry, T. J. Fahey, J. D. Albert, Y. Fong, D. Hesse, B. Beutler, K. R. Manogue, S. Calvano, H. Wei, et al. 1987. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 106:415-422.
30. Tyrrell, D. A., J. D. Almeida, D. M. Berry, et al. 1968. Coronaviruses. Nature (London) 220:650-652.
31. Wang, D., H. Yeger, and E. Cutz. 1996. Expression of gastrin releasing peptide receptor gene in developing lung. Am. J. Respir. Cell Mol. Biol. 14:409-416.
32. Yuwaraj, S., M. Cattral, M. Pope, and G. A. Levy. 1996. Murine hepatitis virus: molecular biology and pathogenesis. Viral Hepatitis 2:125-142.
33. Zimmerman, H. J., and K. G. Ishak. 1982. Valproate-induced hepatic injury: analysis of 23 fatal cases. Hepatology 2:591-597.